Annexes to the interim recommendations for use of theChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII  COVISHIELD™)

Overview

These are the annexes to WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19. Annexes 1–6  contain  tables  that  summarize  the  grading  of  recommendations,  assessment,  development  and  evaluations  (GRADE).  Annexes  7–9  contain  the  SAGE  evidence-to-recommendation  framework  tables  (ETR  tables).

GRADE and ETR tables are updated as recommendations are updated.

This document has been updated: version 15 March 2022.